Literature DB >> 3533567

Dose response and length of action of nifedipine capsules and tablets in patients with essential hypertension: a randomised crossover study.

F P Cappuccio, N D Markandu, F A Tucker, G A MacGregor.   

Abstract

Twelve patients with essential hypertension on no other drug treatment were entered into a randomised crossover study of 5, 10 and 20 mg capsules of nifedipine given 3 times a day and 20 mg tablets given twice a day. Each dose was given for 2 weeks in a random order. All forms of nifedipine were effective in lowering blood pressure. However, 5 mg capsules were less effective than the 10 and 20 mg capsules or 20 mg tablets. There was little to choose between the latter. All doses of nifedipine were more effective 1 and 3 h after the dose compared to subsequent times afterwards. Indeed, as time elapsed after the last dose up to 12 h, there was a gradual increase in blood pressure. However, even at 12 h the 10, 20 mg capsules and 20 mg tablets were still causing an approximate 10% reduction in blood pressure. Nifedipine tablets are as effective as capsules though they might be longer acting, particularly around 6 h after the last dose.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533567     DOI: 10.1007/bf00608223

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Antihypertensive effect of cardiovascular Ca2+-antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade.

Authors:  K Aoki; S Kondo; A Mochizuki; T Yoshida; S Kato; K Kato; K Takikawa
Journal:  Am Heart J       Date:  1978-08       Impact factor: 4.749

2.  Nifedipine, a new antihypertensive with rapid action.

Authors:  M Guazzi; M T Olivari; A Polese; C Fiorentini; F Magrini; P Moruzzi
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

3.  Treatment of hypertension with nifedipine, a calcium antagonistic agent.

Authors:  M T Olivari; C Bartorelli; A Polese; C Fiorentini; P Moruzzi; M D Guazzi
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

4.  Controlled trial of nifedipine and bendroflumethiazide in hypertension.

Authors:  L Hallin; L Andrén; L Hansson
Journal:  J Cardiovasc Pharmacol       Date:  1983 Nov-Dec       Impact factor: 3.105

5.  Acute antihypertensive effect and pharmacokinetics of a tablet preparation of nifedipine.

Authors:  O Banzet; J N Colin; M Thibonnier; E Singlas; J M Alexandre; P Corvol
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Pharmacokinetics and metabolism of nifedipine.

Authors:  K D Raemsch; J Sommer
Journal:  Hypertension       Date:  1983 Jul-Aug       Impact factor: 10.190

7.  Pressor factors and cardiovascular pressor responsiveness after short-term antihypertensive therapy with the calcium antagonist nifedipine alone or combined with a diuretic.

Authors:  C Marone; S Luisoli; F Bomio; C Beretta-Piccoli; M G Bianchetti; P Weidmann
Journal:  J Hypertens Suppl       Date:  1984-12

8.  Pharmacokinetic studies of nifedipine tablet. Correlation with antihypertensive effects.

Authors:  A M Taburet; E Singlas; J N Colin; O Banzet; M Thibonnier; P Corvol
Journal:  Hypertension       Date:  1983 Jul-Aug       Impact factor: 10.190

9.  The acute response to nifedipine is related to pre-treatment blood pressure.

Authors:  G A MacGregor; N D Markandu; C Rotellar; S J Smith; G A Sagnella
Journal:  Postgrad Med J       Date:  1983       Impact factor: 2.401

10.  Nifedipine in the treatment of hypertension: report of a double-blind controlled trial.

Authors:  S Bayley; R J Dobbs; B F Robinson
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

View more
  1 in total

Review 1.  Nifedipine and hypertension: roles of vasodilation and sodium balance.

Authors:  G A MacGregor
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.